November/December 1999

Vol 6, No 6 CME Pretest

This Journal provides 4 hours of Category 1 Continuing Medical Education

Complimentary CME Credits

Physicians can earn 4 credit hours of Category 1 for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions in the posttest at the end of this issue. Complete instructions are given on the posttest pages. Successfully answering 30 or more questions will earn 4 credit hours. CME is presented by an unrestricted educational grant from Bristol-Myers Squibb Oncology Division.

Educational Objectives

After reading this issue of Cancer Control, clinicians will be expected to:

• describe optimal chemo therapy for testis cancer,
• utilize the Mainz classification of renal tumors,
• recognize that partial nephrectomy is a valid treatment for some renal carcinomas,
• understand prevention and new prognostic opportunities for prostate cancer, and

• appreciate the importance of community culture in defining community health care programs.

Release Date: November 1, 1999
Expiration Date: November 1, 2000

Pretest

1. Which drug appears key to the success of chemotherapy regimens for testis cancer?

a. cisplatin

b. dactinomycin

c. etoposide

d. bleomycin

2. What is the most accurate tool for detecting local recurrence after partial nephrectomy for renal cancer?

a. magnetic resonance imaging (MRI)

b. positron emission tomography (PET) scanning

c. ultrasound

d. computed tomography (CT) scanning

3. The intervention A Su Salud (To Your Health) is a successful community intervention among Hispanic and Latino populations. Who initiates the one-on-one cancer education and positive social reinforcement communications?

a. public health workers

b. community leaders

c. volunteer nurses

d. local physicians